Bidirectional Risk Modulator and Modifier Variant of Dilated and Hypertrophic Cardiomyopathy in <i>BAG3</i>

BAG3 C151R was identified as a bidirectional modulator of risk along the DCM-HCM spectrum, as well as an important genetic modifier variant in TTN-mediated DCM. This work expands on the understanding of the etiology and penetrance of DCM, suggesting that BAG3 C151R is an important genetic modifier variant contributing to the variable expressivity of DCM, warranting further exploration of its mechanisms and of genetic modifiers in DCM more broadly.

Authors

Institutions

Publication Details

Journal
JAMA Cardiology
Published
2024-11-13
DOI
https://doi.org/10.1001/jamacardio.2024.3547
Citations
7
Primary Topic
Cardiomyopathy and Myosin Studies
Type
article
Field-Weighted Citation Impact
2.81
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Bidirectional Risk Modulator and Modifier Variant of Dilated and Hypertrophic Cardiomyopathy in BAG3

Melissa Kelly, Nosheen Reza, Ray E. Hershberger, Jonathan O. Mead et al.
7 citations
JAMA Cardiology
Cardiomyopathy and Myosin Studies
2.81
article

Bidirectional Risk Modulator and Modifier Variant of Dilated and Hypertrophic Cardiomyopathy in BAG3

Melissa Kelly, Nosheen Reza, Ray E. Hershberger, Jonathan O. Mead, ANJALI TIKU OWENS, Renae Judy, Eric Carruth, Colleen Morse Kripke, Daniel D. Kinnamon, Michael G. Levin, Anurag Verma, Scott M. Damrauer, Amalia A. Winters, David Zhang, Joseph Park, Lisa Bastarache, Marylyn D. Ritchie, Daniel J. Rader
article en
7 citations

Abstract

BAG3 C151R was identified as a bidirectional modulator of risk along the DCM-HCM spectrum, as well as an important genetic modifier variant in TTN-mediated DCM. This work expands on the understanding of the etiology and penetrance of DCM, suggesting that BAG3 C151R is an important genetic modifier variant contributing to the variable expressivity of DCM, warranting further exploration of its mechanisms and of genetic modifiers in DCM more broadly.

JAMA CardiologyVol. 9(12)
NewYork–Presbyterian Hospital (US), Cornell University (US), New York Hospital Queens (US), Presbyterian Hospital (US), Autism & Developmental Medicine Institute (US), Lung Institute (US), Translational Therapeutics (United States) (US), Philadelphia VA Medical Center (US), Genomic Health (United States) (US), The Ohio State University (US), Geisinger Health System (US), University of Pennsylvania (US), Vanderbilt University Medical Center (US)
Good health and well-being
Openalex Percentile: Top 8%
Cardiomyopathy and Myosin Studies
2.81
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.